Navegando por Autor "Marmo, Vitor Luca Moura"
Agora exibindo 1 - 7 de 7
Resultados por página
Opções de Ordenação
Item Desenvolvimento de um Método de Nanoprecipitação para o Aprisionamento de Fármaco em nanopartículas de Poli-e- Caprolactona(2022-11-07) Pinto, Bruna Cristina dos Santos; Marmo, Vitor Luca Moura; Ambrósio, Jéssica Aparecida Ribeiro; Simioni, Andreza Ribeiro; Beltrame Junior, MiltonItem Estudo do efeito da concentração de gelatina na morfologia e no grau de intumescimento do hidrogel(2022) Ambrosio, Jéssica Aparecida Ribeiro; Pinto, Bruna Cristina dos Santos; Marmo, Vitor Luca Moura; Simioni, Andreza RibeiroItem Estudo do efeito da concentração de gelatina na morfologia e no grau de intumescimento do hidrogel(2022) Ambrosio, Jéssica Aparecida Ribeiro; Pinto, Bruna Cristina dos Santos; Marmo, Vitor Luca Moura; Simioni, Andreza RibeiroItem Hydroxyapatite microspheres used as a drug delivery system for gliosarcoma strain 9l/Lacz treatment by photodynamic therapy protocols(Elsevier) Ambrósio, Jéssica Aparecida Ribeiro; Marmo, Vitor Luca Moura; Gonçalves, Érika Peterson; Pinto, Juliana Guerra; Ferreira-Strixino, Juliana; Raniero, Leandro José; Beltrame Junior, Milton; Simioni, Andreza RibeiroBackground: Hydroxyapatite (HAp) presents similarities with the human bone structure and presents properties such as biodegradability, biocompatibility, and osteoconductivity, which favors its use in prostheses implants and enables its use as a vehicle for the delivery of photosensitizers (PS) from systems of release (DDS) for photodynamic therapy applications Methods: In this work was to synthesized hydroxyapatite microspheres (meHAp), encapsulated with chloroaluminium phthalocyanine (ClAlPc), for DDS. meHAp was synthesized using vaterite as a template. The drug was encapsulated by mixing meHAp and a 50.0 mg.mL− 1 ClAlPc solution. Photochemical, photophysical, and photobiological studies characterized the system. Results: The images from the SEM analysis showed the spherical form of the particles. All spectroscopic results showed excellent photophysical parameters of the drug studied when served in the meHAp system. The incorporation efficiency was 57.8 %. The trypan blue exclusion test results showed a significant reduction (p < 0.05) in cell viability for the groups treated with PDT at all concentrations above 250 μg.mL− 1 . In 9 L/lacZ gliosarcoma cells, PDT mediated at concentrations from 250 to 62.5 µg.mL− 1 reduced cell viability by more than 98 %. In the cell internalization study, it was possible to observe the internalization of phthalocyanines at 37 ◦C, with the accumulation of PS in the cytoplasm and inside the nucleus in the two tested concentrations. Conclusions: From all the results presented throughout the article, the meHAp system shows promise for use as a modified release system (DSD) in photodynamic therapy.Item Synthesis and characterization of photosensitive gelatin-based hydrogels for photodynamic therapy in HeLa-CCL2 cell line(Elsevier) Ambrósio, Jéssica Aparecida Ribeiro; Pinto, Bruna Cristina dos Santos; Marmo, Vitor Luca Moura; Santos, Kennedy Wallace dos; Beltrame Junior, Milton; Pinto, Juliana Guerra; Ferreira-Strixino, Juliana; Raniero, Leandro José; Simioni, Andreza RibeiroBackground: Hydrogel systems are increasingly gaining visibility involving biomedicine, tissue engineering, environmental treatments, and drug delivery systems. These systems have a three-dimensional network composition and high-water absorption capacity, are biocompatible, allowing them to become an option as photosensitizer carriers (PS) for applications in Photodynamic Therapy (PDT) protocols. Methods: A nanohydrogel system (NAHI), encapsulated with chloroaluminium phthalocyanine (ClAlPc) was synthesized for drug delivery.. NAHI was synthesized using gelatin as based polymer by the chemical cross-linking technique. The drug was encapsulated by immersing the hydrogel in a 1.0 mg.mL 1 ClAlPc solution. The external morphology of NAHI was examined by scanning electron microscopy (SEM). The degree of swelling of the synthesized system was evaluated to determine the water absorption potential. The produced nanohydrogel system was characterized by photochemical, photophysical and photobiologial studies. Results: The images from the SEM analysis showed the presence of three-dimensional networks in the formulation. The swelling test demonstrated that the nanohydrogel freeze-drying process increases its water holding capacity. All spectroscopic results showed excellent photophysical parameters of the drug studied when served in the NAHI system. The incorporation efficiency was 70%. The results of trypan blue exclusion test have shown significant reduction (p < 0.05) in the cell viability for all groups treated with PDT, in all concentrations tested. In HeLa cells, PDT mediated by 0,5 mg.mL 1 ClAlPc encapsulated in NAHI showed a decrease in survival close to 95%. In the internalization cell study was possible to observe the internalization of phthalocyanine after one hour of incubation, at 37 ◦C, with the the accumulation of PS in the cytoplasm and inside the nucleus at both concentrations tested. Conclusions: Given the peculiar performance of the selected system, the resulting nanohydrogel is a versatile platform and display potential applications as controlled delivery systems of photosensitizer for photodynamic therapy application.Item Synthesis, characterization, and evaluation of chloroaluminium phthalocyanine incorporated in poly(ε-caprolactone) nanoparticles for photodynamic therapy(Elsevier) Pinto, Bruna Cristina dos Santos; Ambrósio, Jéssica Aparecida Ribeiro; Marmo, Vitor Luca Moura; Pinto, Juliana Guerra; Raniero, Leandro José; Ferreira-Strixino, Juliana; Simioni, Andreza Ribeiro; Beltrame Junior, MiltonBackground: The use of nanotechnology has been widely used in biomedical science, including orthopedic implants, tissue engineering, cancer therapy and drug elution from nanoparticle systems, such as poly-caprolactone (PCL) nanoparticles, which stand out mainly for their biocompatibility, being considered as effective carriers for photosensitizing drugs (PS) in photodynamic therapy (PDT) protocols. Methods: This manuscript describes the synthesis and characterization of PCL nanoparticles for controlled release of the drug chloro-aluminum phthalocyanine (ClAlPc) as a photosensitizer for application in PDT. The PCL-ClAlPc nanoparticles were developed by the nanoprecipitation process. The structure and morphology of the nanoparticles were studied with scanning electron microscopy (SEM) and with Fourier transform infrared (FTIR). The size of nanomaterials was studied using the Dynamic Light Scattering (DLS) method. Photophysical and photochemical characterizations were performed. Subsequently, photobiological studies were also used to characterize the system. Results: The nanoparticles had an average diameter of 384.7 ± 138.6 nm and a polydispersity index of 0.153. SEM analysis revealed that the system formed a spherical shape typical of these delivery systems. Charging efficiency was 82.1% ± 1.2%. The phthalocyanine-loaded PCL nanoparticles maintained their photophysical behavior after encapsulation. Cell viability was determined after the dark toxicity test, and it was possible to observe that there was no evidence of toxicity in the dark, for all concentrations tested. The assay also revealed that adenocarcinoma cells treated with free ClAlPc and in the nanoformulation showed 100% cell death when subjected to PDT protocols. The intracellular location of the photosensitizer indicated a high potential for accumulation in the cytoplasm and nucleus. Conclusions: From the photophysical, photochemical and photobiological analyzes obtained, it was possible to observe that the development of PCL nanoparticles encapsulated with ClAlPc, by the nanoprecipitation method was adequate and that the in vivo release study is efficient to reduce the release rate and attenuate the burst of PS loaded on PCL nanoparticles. The results reinforce that the use of this system as drug delivery systems is useful in PDT protocols.Item Vaterite microparticle-loaded methylene blue for photodynamic activity in macrophages infected with Leishmania braziliensis(Springer Nature) Marmo, Vitor Luca Moura; Ambrósio, Jéssica Aparecida Ribeiro; Gonçalves, Érika Peterson; Raniero, Leandro José; Beltrame Junior, Milton; Pinto, Juliana Guerra; Ferreira-Strixino, Juliana; Simioni, Andreza RibeiroCalcium carbonate (CaCO3) exhibits a variety of crystalline phases, including the anhydrous crystalline polymorphs calcite, aragonite, and vaterite. Developing porous calcium carbonate microparticles in the vaterite phase for the encapsulation of methylene blue (MB) as a photosensitizer (PS) for use in photodynamic therapy (PDT) was the goal of this investigation. Using an adsorption approach, the PS was integrated into the CaCO3 microparticles. The vaterite microparticles were characterized by scanning electron microscopy (SEM) and steady-state techniques. The trypan blue exclusion method was used to measure the biological activity of macrophages infected with Leishmania braziliensis in vitro. The vaterite microparticles produced are highly porous, non-aggregated, and uniform in size. After encapsulation, the MB-loaded microparticles kept their photophysical characteristics. The carriers that were captured allowed for dye localization inside the cells. The results obtained in this study indicated that the MB-loaded vaterite microparticles show promising photodynamic activity in macrophages infected with Leishmania braziliensis.